BioNTech

The Biden administration on Wednesday announced a $3.2 billion deal to purchase 105 million doses of Pfizer’s COVID-19 vaccine for a fall vaccination campaign, with options to buy up to 300 million doses.

The company expects to adapt current vaccines to new strains.

The vaccine "is a reasonable cause for transient semen concentration and TMC decline," according to the study.

Centers for Disease Control and Prevention Director Rochelle Walensky on Saturday approved Moderna and Pfizer-BioNTech’s COVID-19 vaccines for use in American children as young as 6...

FDA announcement only says jabs are "authorized," not "approved."

Advisers to the U.S. Food and Drug Administration on Tuesday unanimously recommended that the agency authorize Moderna Inc's (MRNA.O) COVID-19 vaccine for children and teens aged 6 to 17 years of age.

VAERS data released Friday by the Centers for Disease Control and Prevention show 1,295,329 reports of adverse events from all age groups following COVID-19 vaccines, including 28,714 deaths and 236,767 serious injuries between Dec. 14, 2020, and June 3, 2022.

Defending the Republic, a Texas-based non-profit filed a Freedom of Information Act lawsuit against the Food and Drug Administration for refusing to turn over records related to the approval of Moderna’s COVID-19 vaccines.

VAERS data released Friday by the Centers for Disease Control and Prevention show 1,287,595 reports of adverse events from all age groups following COVID-19 vaccines, including 28,532 deaths and 235,041 serious injuries between Dec. 14, 2020, and May 27, 2022.

Young males are more likely to report heart damage following vaccination with an mRNA COVID-19 vaccine, and the damage is more likely to be reported after the second dose, according to research published May 25 in The BMJ.